Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial

(2013) Diana Crivellari et al.   BREAST

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

(2012) Laura Biganzoli et al.   LANCET ONCOLOGY

Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?

(2011) R Leonard et al.   BRITISH JOURNAL OF CANCER

Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

(2011) Martine Extermann et al.   CANCER

Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907

(2011) Alice B. Kornblith et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

(2011) Arti Hurria et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

(2009) Hyman B. Muss et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

(2008) Joseph A. Sparano et al.   NEW ENGLAND JOURNAL OF MEDICINE